A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema

M.B. van Doorn, J. Burggraaf, T. van Dam, A.J. Eerenberg, M. Levi, C.E. Hack, R.C. Schoemaker, A.F. Cohen, J. Nuijens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)876-883
JournalJournal of Allergy and Clinical Immunology
Issue number4
Publication statusPublished - 2005

Cite this